Developer docs
API playgroundTry for free, no card

Search company profiles

Inmunotek

Full company profile

uuid000erzw

Namestring
Inmunotek
Legal namestring
INMUNOTEK, S.L.
Websiteurl
inmunotek.com
Company typeenum
Private
Founded yearint
1992
Descriptiontext

Inmunotek, S.L. is a privately held Spanish pharmaceutical laboratory founded in 1992 and headquartered in Alcalá de Henares, Madrid, with additional manufacturing facilities in San Sebastián de los Reyes and a wholly-owned Greek subsidiary, Inmunotek Hellas, in Athens. The company specializes in the research, development, manufacture, and commercialization of medicines and medical devices for the diagnosis and treatment of allergy and immunology conditions in both human and veterinary pathology. Its core product lines include allergen extracts for in-vivo skin prick diagnosis, allergen immunotherapy vaccines (anti-allergic vaccines), bacterial vaccines and autovaccines, the proprietary Prick-Film system for automated skin allergy testing, and the RhinoDouche family of nasal irrigation devices and saline formulations. All products are manufactured in-house under Good Manufacturing Practice (GMP) standards and are authorized by the Spanish Medicines Agency, with production supported by company-owned laboratories that produce biological raw materials (bacteria, fungi, mites), enabling vertical integration from raw material to finished dosage form.

The company's commercial model is a sales-led B2B motion targeting licensed healthcare professionals (allergists, immunologists, and physicians) through a gated registration portal, direct medical visits, scientific congress participation, and a multilingual website available in Spanish, English, Greek, Portuguese, and German. Products are prescription-based medications and medical devices, with no direct-to-consumer dispensing model, and revenue is generated through one-time sales of allergen extracts, vaccines, and devices to professional customers. Distribution is hybrid: direct in Spain and Greece via the wholly-owned subsidiary, and through a network of third-party distributors across more than 50 countries on all continents. The company operates with a headcount of 51-100 employees, holds no disclosed external funding, and is led by founder Jose Luis Subiza as Founder & CEO, with Mónica Subiza Domínguez serving as Product Manager. In 2026, Inmunotek received the ASPID 2026 award in Madrid and exhibited at the EAACI 2026 European Academy of Allergy and Clinical Immunology congress, both indicative of continued commercial and scientific activity rather than a transformational shift in scale or direction.

Short descriptiontext

Inmunotek, S.L. is a privately held Spanish pharmaceutical laboratory, founded in 1992 and based in Alcalá de Henares, Madrid, that develops, manufactures, and commercializes allergen extracts, immunotherapy vaccines, bacterial autovaccines, and nasal irrigation devices under GMP standards for healthcare professionals across Spain and more than 50 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersAlcalá De Henares, Spain
HQ citystring
Alcalá De Henares
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
allergen extract manufacturing, allergy immunotherapy vaccines, allergen diagnostic devices, nasal irrigation products, bacterial immunotherapy autovaccines
Industry5 codes
PRIMARYHLAIACAF
Pulmonology & Allergy Specialty Pharmaceuticals
SECONDARYHLAAAEAI
Allergy Immunotherapy Biologics (allergen extracts, desensitization)
Healthcare & Life Sciences/Biotechnology & Biologics/Vaccines & Immunization Biologics
SECONDARYHLAIAAAH
Respiratory & Allergy Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAAALAK
Autoimmune & Allergy Diagnostics
SECONDARYHLAMAEAH
Dermatology & Allergy Drugs
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
NAICS code3 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Biological Product (except Diagnostic) Manufacturing325414
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code3 codes
  • Pharmaceutical Preparations2834
  • Biological Products, (No Disgnostic Substances)2836
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Allergy and Immunology Pharmaceuticals
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Allergen Extracts and Vaccines
TypeOne Time License
Description

Manufacture and commercialization of allergen extracts for immunotherapy vaccines (antiallergic vaccines) and bacterial vaccines and mucosal immunotherapies, sold as prescription medicines. Revenue is generated through product sales to healthcare providers and institutions.

inmunotek.com
2Diagnostic Extracts
TypeOne Time License
Description

Production and sale of a wide range of allergen extracts for in vivo allergy diagnosis (prick test) for respiratory and food allergies, as well as diagnostic devices such as Prick-Film and RhinoDouche.

inmunotek.com
3Medical Devices / Health Products
TypeHardware Sales
Description

Commercialization of health products including nasal irrigation devices (RhinoDouche, RhinoDouche Junior) and saline formulations (RhinoDouche Sal).

inmunotek.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Prick-Film®
Description

A system designed to facilitate the performance, reading, and archiving of skin allergy tests through automatic processing.

inmunotek.com
+1 more record
Core offering1 text field

Inmunotek researches, develops, manufactures, and commercializes prescription medicines and medical devices for allergy diagnosis and immunotherapy, along with nasal irrigation products. Its portfolio spans allergen extracts for skin prick testing, anti-allergic therapeutic vaccines, bacterial vaccines and autovaccines, the proprietary Prick-Film diagnostic system, and the RhinoDouche nasal irrigation device line, all manufactured under GMP standards and authorized by the Spanish Medicines Agency.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Inmunotek is a pharmaceutical laboratory specializing in the manufacture and commercialization of products (medicines and medical devices) for allergy and immunology in both human and veterinary pathology. The product portfolio includes allergen extracts for diagnosis (Prick Test), anti-allergic therapeutic vaccines for immunotherapy, bacterial vaccines and autovaccines for immunotherapy, the Prick-Film diagnostic device system, and the RhinoDouche nasal irrigation product line including devices and saline formulations. Products are manufactured under Good Manufacturing Practice (GMP) standards and are authorized by the Spanish Drug Agency, commercialized in Spain and over 50 countries.

Product and service8 records
1Allergen Extracts (Prick Test)
CategoryDiagnostic Product
Description

Allergen extracts used by allergists and clinical immunologists for in vivo diagnosis of respiratory and food allergies through skin prick testing.

2Anti-Allergic Vaccines
CategoryTherapeutic Product
Description

Prescription therapeutic vaccines for allergen immunotherapy used to treat allergic diseases, manufactured under GMP standards for healthcare professionals and patients under medical supervision.

3Bacterial Vaccines and Immunotherapy (Autovaccines)
CategoryTherapeutic Product
Description

Autovaccines prepared from patient biological samples and bacterial vaccines designed to stimulate and improve the immune response against infectious microorganisms, used by physicians for bacterial immunotherapy.

4Prick-Film System
CategoryMedical Device
Description

Proprietary medical device that automates the performance, reading, and archiving of skin allergy tests, enabling rapid and clean cutaneous testing for allergists and immunologists.

5RhinoDouche
CategoryMedical Device
Description

Nasal irrigation medical device that cleans the nasal cavities and paranasal sinuses, sold to healthcare professionals and patients for nasal hygiene and respiratory symptom relief.

6RhinoDouche Junior
CategoryMedical Device
Description

Child-adapted nasal irrigation device with a smaller volume for nasal washes in pediatric patients, distributed alongside the adult RhinoDouche device.

7RhinoDouche Sal XL
CategoryMedical Device
Description

Saline formulation specifically developed for use with the RhinoDouche adult nasal irrigation device to enable nasal and sinus washes.

8RhinoDouche Sal Junior
CategoryMedical Device
Description

Pediatric saline formulation developed for use with the RhinoDouche Junior nasal irrigation device to enable nasal washes in children.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global leader in allergy immunotherapy with both SCIT and SLIT products across respiratory allergies. Directly competes with Inmunotek in prescription allergen vaccines and diagnostics, with substantially larger scale and pipeline.

TypeEmerging player
Description

Austrian biotech developing recombinant allergen-based immunotherapies. Comparable to Inmunotek's allergen focus but represents a next-generation, recombinant approach versus Inmunotek's traditional extract-based portfolio.

TypeDirect peer
Description

Spanish-based specialty pharmaceutical laboratory focused on allergy and immunology products. Operates as a direct domestic competitor to Inmunotek with overlapping allergen extract and immunotherapy vaccine offerings.

TypeBroad incumbent
Description

Global healthcare conglomerate with consumer health and pharmaceutical offerings touching allergy, sinus, and respiratory care. Adjacent competitor to Inmunotek's prescription allergy and OTC nasal irrigation products within a much broader portfolio.

TypeBroad incumbent
Description

Global pharmaceutical major with allergy and respiratory franchises. Overlaps with Inmunotek in allergy/respiratory therapeutics at the portfolio level but competes as a broad incumbent rather than a specialized niche player.

TypeDirect peer
Description

European allergen immunotherapy company producing diagnostic and therapeutic allergen products. Closely comparable to Inmunotek's allergen extract, prick test, and immunotherapy vaccine portfolio.

TypeOthers
Description

Spanish biotech group encompassing veterinary and human health divisions including allergy/immunology through LETI. Comparable as a Spanish-language ecosystem participant and parent of a direct competitor; relevant for understanding the local competitive cluster around Inmunotek.

TypeDirect peer
Description

UK-based specialty pharmaceutical company developing and commercializing allergy immunotherapy vaccines and diagnostics. Directly comparable to Inmunotek in allergen-specific immunotherapy, with a focus on both SCIT and novel approaches.

TypeDirect peer
Description

Specialty biopharmaceutical company focused on allergen immunotherapy diagnosis and treatment. Competes head-to-head with Inmunotek in the prescription allergy vaccine and allergen extract markets globally.

TypeRegional player
Description

German specialty pharmaceutical company focused on allergen diagnostics and immunotherapy. Comparable to Inmunotek in product type but primarily serves German-speaking and Central European markets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Inmunotek

Allergy and Immunology Pharmaceuticalsinmunotek.com

Inmunotek, S.L. is a privately held Spanish pharmaceutical laboratory, founded in 1992 and based in Alcalá de Henares, Madrid, that develops, manufactures, and commercializes allergen extracts, immunotherapy vaccines, bacterial autovaccines, and nasal irrigation devices under GMP standards for healthcare professionals across Spain and more than 50 countries.

What Inmunotek does

Inmunotek, S.L. is a privately held Spanish pharmaceutical laboratory founded in 1992 and headquartered in Alcalá de Henares, Madrid, with additional manufacturing facilities in San Sebastián de los Reyes and a wholly-owned Greek subsidiary, Inmunotek Hellas, in Athens. The company specializes in the research, development, manufacture, and commercialization of medicines and medical devices for the diagnosis and treatment of allergy and immunology conditions in both human and veterinary pathology. Its core product lines include allergen extracts for in-vivo skin prick diagnosis, allergen immunotherapy vaccines (anti-allergic vaccines), bacterial vaccines and autovaccines, the proprietary Prick-Film system for automated skin allergy testing, and the RhinoDouche family of nasal irrigation devices and saline formulations. All products are manufactured in-house under Good Manufacturing Practice (GMP) standards and are authorized by the Spanish Medicines Agency, with production supported by company-owned laboratories that produce biological raw materials (bacteria, fungi, mites), enabling vertical integration from raw material to finished dosage form.

The company's commercial model is a sales-led B2B motion targeting licensed healthcare professionals (allergists, immunologists, and physicians) through a gated registration portal, direct medical visits, scientific congress participation, and a multilingual website available in Spanish, English, Greek, Portuguese, and German. Products are prescription-based medications and medical devices, with no direct-to-consumer dispensing model, and revenue is generated through one-time sales of allergen extracts, vaccines, and devices to professional customers. Distribution is hybrid: direct in Spain and Greece via the wholly-owned subsidiary, and through a network of third-party distributors across more than 50 countries on all continents. The company operates with a headcount of 51-100 employees, holds no disclosed external funding, and is led by founder Jose Luis Subiza as Founder & CEO, with Mónica Subiza Domínguez serving as Product Manager. In 2026, Inmunotek received the ASPID 2026 award in Madrid and exhibited at the EAACI 2026 European Academy of Allergy and Clinical Immunology congress, both indicative of continued commercial and scientific activity rather than a transformational shift in scale or direction.

Inmunotek firmographics

Firmographics
Name
Inmunotek
Legal name
INMUNOTEK, S.L.
Website
https://inmunotek.com
Company type
Private
Founded year
1992
Operating status
Operating
Headcount range
251–500 employees
Short description
Inmunotek, S.L. is a privately held Spanish pharmaceutical laboratory, founded in 1992 and based in Alcalá de Henares, Madrid, that develops, manufactures, and commercializes allergen extracts, immunotherapy vaccines, bacterial autovaccines, and nasal irrigation devices under GMP standards for healthcare professionals across Spain and more than 50 countries.
Ownership category
akta.pro rank

Inmunotek industry classification

Industry
Product category
Allergy and Immunology Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414), In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAIACAF
Pulmonology & Allergy Specialty Pharmaceuticals
SECONDARYHLAAAEAI
Allergy Immunotherapy Biologics (allergen extracts, desensitization)
Healthcare & Life Sciences/Biotechnology & Biologics/Vaccines & Immunization Biologics
SECONDARYHLAIAAAH
Respiratory & Allergy Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAAALAK
Autoimmune & Allergy Diagnostics
SECONDARYHLAMAEAH
Dermatology & Allergy Drugs
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics

Keywords

  • Allergen extract manufacturing
  • Allergy immunotherapy vaccines
  • Allergen diagnostic devices
  • Nasal irrigation products
  • Bacterial immunotherapy autovaccines

Where Inmunotek is headquartered

Location

Headquarters

HQ city
Alcalá De Henares
HQ country
Spain
HQ region
Europe

Offices3 records

Markets served

Inmunotek business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Allergen Extracts and Vaccines: Manufacture and commercialization of allergen extracts for immunotherapy vaccines (antiallergic vaccines) and bacterial vaccines and mucosal immunotherapies, sold as prescription medicines. Revenue is generated through product sales to healthcare providers and institutions.
  2. Diagnostic Extracts: Production and sale of a wide range of allergen extracts for in vivo allergy diagnosis (prick test) for respiratory and food allergies, as well as diagnostic devices such as Prick-Film and RhinoDouche.
  3. Medical Devices / Health Products: Commercialization of health products including nasal irrigation devices (RhinoDouche, RhinoDouche Junior) and saline formulations (RhinoDouche Sal).

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Inmunotek product offering

Product offering

Core offering

Inmunotek researches, develops, manufactures, and commercializes prescription medicines and medical devices for allergy diagnosis and immunotherapy, along with nasal irrigation products. Its portfolio spans allergen extracts for skin prick testing, anti-allergic therapeutic vaccines, bacterial vaccines and autovaccines, the proprietary Prick-Film diagnostic system, and the RhinoDouche nasal irrigation device line, all manufactured under GMP standards and authorized by the Spanish Medicines Agency.

Product overview

Inmunotek is a pharmaceutical laboratory specializing in the manufacture and commercialization of products (medicines and medical devices) for allergy and immunology in both human and veterinary pathology. The product portfolio includes allergen extracts for diagnosis (Prick Test), anti-allergic therapeutic vaccines for immunotherapy, bacterial vaccines and autovaccines for immunotherapy, the Prick-Film diagnostic device system, and the RhinoDouche nasal irrigation product line including devices and saline formulations. Products are manufactured under Good Manufacturing Practice (GMP) standards and are authorized by the Spanish Drug Agency, commercialized in Spain and over 50 countries.

Differentiator

Problem solved

Functional benefit

Brands

  • Prick-Film®: A system designed to facilitate the performance, reading, and archiving of skin allergy tests through automatic processing.
  • RhinoDouche®

Products and services

  • Allergen Extracts (Prick Test) Allergen extracts used by allergists and clinical immunologists for in vivo diagnosis of respiratory and food allergies through skin prick testing.
  • Anti-Allergic Vaccines Prescription therapeutic vaccines for allergen immunotherapy used to treat allergic diseases, manufactured under GMP standards for healthcare professionals and patients under medical supervision.
  • Bacterial Vaccines and Immunotherapy (Autovaccines) Autovaccines prepared from patient biological samples and bacterial vaccines designed to stimulate and improve the immune response against infectious microorganisms, used by physicians for bacterial immunotherapy.
  • Prick-Film System Proprietary medical device that automates the performance, reading, and archiving of skin allergy tests, enabling rapid and clean cutaneous testing for allergists and immunologists.
  • RhinoDouche Nasal irrigation medical device that cleans the nasal cavities and paranasal sinuses, sold to healthcare professionals and patients for nasal hygiene and respiratory symptom relief.
  • RhinoDouche Junior Child-adapted nasal irrigation device with a smaller volume for nasal washes in pediatric patients, distributed alongside the adult RhinoDouche device.
  • RhinoDouche Sal XL Saline formulation specifically developed for use with the RhinoDouche adult nasal irrigation device to enable nasal and sinus washes.
  • RhinoDouche Sal Junior Pediatric saline formulation developed for use with the RhinoDouche Junior nasal irrigation device to enable nasal washes in children.

Companies that use Inmunotek

Customer profile

Segments2 records

Ideal customer profiles2 records

Inmunotek technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Inmunotek partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Inmunotek competitors and assessment

Company assessment

Direct peers

  • ALK-Abelló: Global leader in allergy immunotherapy with both SCIT and SLIT products across respiratory allergies. Directly competes with Inmunotek in prescription allergen vaccines and diagnostics, with substantially larger scale and pipeline.
  • LETI Pharma: Spanish-based specialty pharmaceutical laboratory focused on allergy and immunology products. Operates as a direct domestic competitor to Inmunotek with overlapping allergen extract and immunotherapy vaccine offerings.
  • HAL Allergy: European allergen immunotherapy company producing diagnostic and therapeutic allergen products. Closely comparable to Inmunotek's allergen extract, prick test, and immunotherapy vaccine portfolio.
  • Allergy Therapeutics: UK-based specialty pharmaceutical company developing and commercializing allergy immunotherapy vaccines and diagnostics. Directly comparable to Inmunotek in allergen-specific immunotherapy, with a focus on both SCIT and novel approaches.
  • Stallergenes Greer: Specialty biopharmaceutical company focused on allergen immunotherapy diagnosis and treatment. Competes head-to-head with Inmunotek in the prescription allergy vaccine and allergen extract markets globally.

Emerging players

  • Biomay: Austrian biotech developing recombinant allergen-based immunotherapies. Comparable to Inmunotek's allergen focus but represents a next-generation, recombinant approach versus Inmunotek's traditional extract-based portfolio.

Broad incumbents

  • Bayer: Global healthcare conglomerate with consumer health and pharmaceutical offerings touching allergy, sinus, and respiratory care. Adjacent competitor to Inmunotek's prescription allergy and OTC nasal irrigation products within a much broader portfolio.
  • Sanofi: Global pharmaceutical major with allergy and respiratory franchises. Overlaps with Inmunotek in allergy/respiratory therapeutics at the portfolio level but competes as a broad incumbent rather than a specialized niche player.

Others

  • Zendal Group: Spanish biotech group encompassing veterinary and human health divisions including allergy/immunology through LETI. Comparable as a Spanish-language ecosystem participant and parent of a direct competitor; relevant for understanding the local competitive cluster around Inmunotek.

Regional players

  • Roxall Medizin: German specialty pharmaceutical company focused on allergen diagnostics and immunotherapy. Comparable to Inmunotek in product type but primarily serves German-speaking and Central European markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Inmunotek social profiles

Digital presence

Inmunotek compliance and trust

Trust signal

Compliance1 record

Inmunotek financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Inmunotek leadership team

Management profile

Number of profiles

Profiles2 records

Inmunotek subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Inmunotek funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Inmunotek M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Inmunotek

What does Inmunotek do?

Inmunotek researches, develops, manufactures, and commercializes prescription medicines and medical devices for allergy diagnosis and immunotherapy, along with nasal irrigation products. Its portfolio spans allergen extracts for skin prick testing, anti-allergic therapeutic vaccines, bacterial vaccines and autovaccines, the proprietary Prick-Film diagnostic system, and the RhinoDouche nasal irrigation device line, all manufactured under GMP standards and authorized by the Spanish Medicines Agency.

Is Inmunotek a public or private company?

Inmunotek is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Inmunotek founded?

Inmunotek was founded in 1992. It employs 251 to 500 people.

Where is Inmunotek based?

Inmunotek is headquartered in Alcalá De Henares, Spain, in the Europe region.

How does Inmunotek make money?

Three revenue lines are on record. Allergen Extracts and Vaccines are the primary driver. The others are diagnostic Extracts and medical Devices / Health Products.

Who are Inmunotek's main competitors?

Direct peers on record are ALK-Abelló, LETI Pharma, HAL Allergy, Allergy Therapeutics and Stallergenes Greer. Biomay is listed as an emerging player. Broad incumbents are Bayer and Sanofi. Zendal Group is listed as an others. Roxall Medizin is listed as a regional player.

Does Inmunotek have an API?

No public API is recorded for Inmunotek.

What industry is Inmunotek in?

Inmunotek's product category is Allergy and Immunology Pharmaceuticals. Its primary akta.pro industry code is HLAIACAF, Pulmonology & Allergy Specialty Pharmaceuticals, with a secondary code of HLAAAEAI, Allergy Immunotherapy Biologics (allergen extracts, desensitization). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals